These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1968151)

  • 1. Residual bcr/abl transcripts in chronic myeloid leukaemia.
    Gabert J; Thuret I; Carcassonne Y; Maraninchi D; Mannoni P
    Lancet; 1990 Feb; 335(8686):417-8. PubMed ID: 1968151
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation.
    Gabert J; Thuret I; Lafage M; Carcassonne Y; Maraninchi D; Mannoni P
    Lancet; 1989 Nov; 2(8672):1125-8. PubMed ID: 2572849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time quantification for BCR-ABL transcripts in chronic myeloid leukaemia patients in UKMMC, Malaysia.
    Wong FL; Hamidah NH; Hawa AA; Nurul AN; Leong CF; Saw F; Ainoon O
    Malays J Pathol; 2011 Dec; 33(2):107-12. PubMed ID: 22299211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
    MacKenzie E; Stewart E; Birnie GD
    Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction.
    Hochhaus A; Lin F; Reiter A; Skladny H; Hehlmann R; Goldman JM; Cross NC
    Leukemia; 1997 Apr; 11 Suppl 3():541-4. PubMed ID: 9209451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
    Beránek M; Voglová J; Sýkorová A; Belada D; Bláha M
    Cas Lek Cesk; 2006; 145(1):25-9; discussion 29-30. PubMed ID: 16468238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors.
    Keating A
    Stem Cells; 1993 Oct; 11 Suppl 3():31-3. PubMed ID: 8298475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light microscopic detection of BCR-ABL transcripts after in-cell RT-PCR: fusion gene expression might correlate with clinical evolution of chronic myeloid leukemia.
    Balatzenko G; Guenova M
    Leuk Lymphoma; 2000 Jan; 36(3-4):383-96. PubMed ID: 10674911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.
    Mondal BC; Majumdar S; Dasgupta UB; Chaudhuri U; Chakrabarti P; Bhattacharyya S
    J Clin Pathol; 2006 Oct; 59(10):1102-3. PubMed ID: 17021137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized Molecular Monitoring for Variant BCR-ABL1 Transcripts in Chronic Myeloid Leukemia.
    Langabeer SE
    Arch Pathol Lab Med; 2015 Aug; 139(8):969. PubMed ID: 26230589
    [No Abstract]   [Full Text] [Related]  

  • 12. Absolute quantification of BCR-ABL1 fusion transcripts in pediatric chronic myeloid leukemia.
    Tang Y; Wei X; Chen J; Du Y; Chu H; Mao L; Chen J; Xu Q; Tang J; Shen S; Mao M
    Leuk Lymphoma; 2016 Sep; 57(9):2216-8. PubMed ID: 27095369
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
    Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y
    Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
    Langabeer SE; Gale RE; Harvey RC; Cook RW; Mackinnon S; Linch DC
    Leukemia; 2002 Mar; 16(3):393-9. PubMed ID: 11896544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Ph+ acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts.
    Williams BG; Yin JL; Ma DD
    Leuk Lymphoma; 1994 Jul; 14(3-4):341-6. PubMed ID: 7950925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
    Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
    J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
    Kreuzer KA; Lass U; Bohn A; Landt O; Schmidt CA
    Cancer Res; 1999 Jul; 59(13):3171-4. PubMed ID: 10397261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
    Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.